(Q34628656)

3 August 2017

1 reference

title

Partial fatty acid oxidation inhibitors for stable angina (English)

1 reference

3 August 2017

0 references

1 reference

William C Stanley

1

1 reference

PubMed ID

11996644

3 August 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

Expert Opinion on Investigational Drugs

3 August 2017

1 reference

3 August 2017

11

1 reference

3 August 2017

615-629

1 reference

3 August 2017

5

1 reference

Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions

3 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Regulation of fatty acid oxidation in the mammalian heart in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Energy metabolism of the heart: from basic concepts to clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Cardiac fatty acid uptake and transport in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Regulation of pyruvate dehydrogenase in rat heart. Mechanism of regulation of proportions of dephosphorylated and phosphorylated enzyme by oxidation of fatty acids and ketone bodies and of effects of diabetes: role of coenzyme A, acetyl-coenzyme A a

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Active and inactive forms of pyruvate dehydrogenase in rat heart and kidney: effect of diabetes, fasting, and refeeding on pyruvate dehydrogenase interconversion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Relative importance of pyruvate dehydrogenase interconversion and feed-back inhibition in the effect of fatty acids on pyruvate oxidation by rat heart mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Starvation and diabetes increase the amount of pyruvate dehydrogenase kinase isoenzyme 4 in rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Ranolazine: a novel metabolic modulator for the treatment of angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Effects of pH on the myofilaments and the sarcoplasmic reticulum of skinned cells from cardiace and skeletal muscles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Amiloride delays the ischemia-induced rise in cytosolic free calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Pyruvate dehydrogenase activity and malonyl CoA levels in normal and ischemic swine myocardium: effects of dichloroacetate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Contemporary management of chronic stable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Drug therapy. Combined beta-adrenergic and calcium-entry blockade in angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Clostridium difficile colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Two mechanisms produce tissue-specific inhibition of fatty acid oxidation by oxfenicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

The effect of Oxfenicine on cardiac carbohydrate metabolism in intact dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

An in vitro method for the evaluation of antiarrhythmic and antiischemic agents by using programmed electrical stimulation of rabbit heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Limitation of myocardial infarct size by metabolic interventions that reduce accumulation of fatty acid metabolites in ischemic myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Comparative trial of perhexiline maleate and oxprenolol in patients with angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Population pharmacokinetics of perhexiline from very sparse, routine monitoring data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Impaired oxidation of debrisoquine in patients with perhexiline liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Impaired oxidation of debrisoquine in patients with perhexiline neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Modification of left ventricular hypertrophy by chronic etomixir treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Some biochemical aspects of the protective effect of trimetazidine on rat cardiomyocytes during hypoxia and reoxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Effects of trimetazidine on the contractile response of chronically dysfunctional myocardium to low-dose dobutamine in ischaemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

The use of ranolazine in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Protective effects of ranolazine in guinea-pig hearts during low-flow ischaemia and their association with increases in active pyruvate dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

Cardioprotective effects of ranolazine (RS-43285) in the isolated perfused rabbit heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.11.5.615

10.1517/13543784.11.5.615

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

11996644